CollPlant implementing cost-reduction and workforce optimization plan

The company said, “To ensure we are well positioned for the road ahead, we have updated our expense forecast and are implementing a cost-reduction and workforce optimization plan. As part of this initiative, we are in the process of reducing our workforce by approximately 50%. We are confident these measures will sharpen our focus and believe this will extend our cash runway into Q4 2026, positioning us to achieve our next key milestones from a position of strength. As we move forward, we are building on a strong foundation, with three core programs – regenerative dermal and soft tissue fillers, regenerative breast implants, and rhCollagen bioinks for 3D bioprinting of tissues and organs – that we believe have the potential to drive meaningful growth and value creation in the years ahead.”